IOVANCE BIOTHERAPEUTICS, INC. Interest Income (Expense), Net
IOVANCE BIOTHERAPEUTICS, INC. (IOVA) reported Interest Income (Expense), Net of $221.00 thousand for the 3-month period ending 2016-09-30, per its 10-Q filed 2016-11-04.
Discontinued › Income Statement › Other Income
us-gaap:InterestIncomeExpenseNet · last filed 2016-11-04
- IOVANCE BIOTHERAPEUTICS, INC. interest income (expense), net for the quarter ending 2016-09-30 was $221.00K, a 2662.50% increase year-over-year.
- IOVANCE BIOTHERAPEUTICS, INC. interest income (expense), net for the quarter ending 2016-06-30 was $164.00K, a 124.66% increase year-over-year.
- IOVANCE BIOTHERAPEUTICS, INC. interest income (expense), net for the quarter ending 2016-03-31 was $126.00K.
- IOVANCE BIOTHERAPEUTICS, INC. interest income (expense), net for the quarter ending 2015-12-31 was $119.00K.
- IOVANCE BIOTHERAPEUTICS, INC. interest income (expense), net for fiscal 2015 was $200.00K, a 3233.33% increase from fiscal 2014.
- IOVANCE BIOTHERAPEUTICS, INC. interest income (expense), net for fiscal 2014 was $6.00K.
- IOVANCE BIOTHERAPEUTICS, INC. interest income (expense), net for fiscal 2013 was -$445.00K.
- IOVANCE BIOTHERAPEUTICS, INC. interest income (expense), net for fiscal 2012 was -$1.92M.
| Period end | Interest Income (Expense), Net 3 month | Interest Income (Expense), Net 6 month | Interest Income (Expense), Net 9 month | Interest Income (Expense), Net 12 month | Interest Income (Expense), Net 12 month as first filed | Interest Income (Expense), Net 72 month |
|---|---|---|---|---|---|---|
| 2016-09-30 | $221.00K 10-Q · filed 2016-11-04 | $385.00K derived: sum of 2 quarters · filed 2016-11-04 | $511.00K 10-Q · filed 2016-11-04 | $630.00K derived: sum of 4 quarters · filed 2016-11-04 | ||
| 2016-06-30 | $164.00K 10-Q · filed 2016-08-09 | $290.00K 10-Q · filed 2016-08-09 | $409.00K derived: sum of 3 quarters · filed 2016-08-09 | $417.00K derived: sum of 4 quarters · filed 2016-11-04 | ||
| 2016-03-31 | $126.00K 10-Q · filed 2016-05-09 | $245.00K derived: sum of 2 quarters · filed 2016-05-09 | $253.00K derived: sum of 3 quarters · filed 2016-11-04 | $326.00K derived: sum of 4 quarters · filed 2016-11-04 | ||
| 2015-12-31 | $119.00K derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-11 | $127.00K derived: sum of 2 quarters · filed 2016-11-04 | $200.00K derived: sum of 3 quarters · filed 2016-11-04 | $200.00K 10-K · filed 2016-03-11 | ||
| 2015-09-30 | $8.00K 10-Q · filed 2016-11-04 | $81.00K derived: sum of 2 quarters · filed 2016-11-04 | $81.00K 10-Q · filed 2016-11-04 | |||
| 2015-06-30 | $73.00K 10-Q · filed 2016-08-09 | $73.00K 10-Q · filed 2016-08-09 | ||||
| 2015-03-31 | $0.00 10-Q · filed 2016-05-09 | |||||
| 2014-12-31 | $6.00K 10-K · filed 2016-03-11 | |||||
| 2013-12-31 | -$445.00K 10-K · filed 2016-03-11 | -$444.73K 10-K · filed 2014-03-28 | -$2.52M 10-K · filed 2014-03-28 | |||
| 2012-12-31 | -$1.92M 10-K · filed 2014-03-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Adaptive Biotechnologies Corp (ADPT) | United States | $4.719B | -53.43 |
| CRISPR Therapeutics AG (CRSP) | $5.390B | -11.68 | |
| Relay Therapeutics, Inc. (RLAY) | United States | $3.884B | -14.30 |
| Scholar Rock Holding Corp (SRRK) | United States | $5.920B | -16.37 |
| CG Oncology, Inc. (CGON) | United States | $6.095B | -27.95 |
| Tarsus Pharmaceuticals, Inc. (TARS) | United States | $3.329B | -58.60 |
| Denali Therapeutics Inc. (DNLI) | United States | $3.274B | -8.04 |
| Immunovant, Inc. (IMVT) | United States | $7.028B | -14.78 |
| Beam Therapeutics Inc. (BEAM) | United States | $2.549B | -41.51 |
| Greenland Mines Ltd (GRML) | United States | $2.362B |